Trial
NCT05987176
Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
The Taylor Family 2010 Charitable Trust; Novartis/AAA
Condition
Neuroendocrine Tumor G1 (NET G1)/Carcinoid
Intervention
Lutathera
Why stopped
The study has closed earlier than planned due to one of the funders decision to withdraw the financial support for the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-14